Abstract

BackgroundNon-alcoholic fatty liver disease (NAFLD) is a multifactorial disease with a complex pathophysiology. The clinical features of NAFLD include obesity, insulin resistance (IR) and dyslipidemia. Consumption of a diet high in saturated fats and sucrose is an important factor in the increasing occurrence of these metabolic disorders, primarily NAFLD and IR. We sought to assess the role of a high-fat, high-sucrose (HFS) diet in the promotion of NAFLD and to evaluate the effects of quercetin (Q), berberine (BB) and o-coumaric acid (CA) on modulation of these disorders.MethodsFifty male rats were divided into 2 main groups as follows: group 1 comprised 10 rats fed a standard diet (SD), and group 2 comprised 40 rats fed an HFS diet for 6 weeks and then subdivided equally into 4 groups; one of these groups served as the HFS diet and each of the other three groups received daily supplementation with either Q, CA or BB for 6 weeks.ResultsIn the present study, several metabolic disorders were induced in our laboratory animal model, as evidenced by histological and biochemical changes. These alterations included serum and hepatic dyslipidemia (i.e., increased triglyceride, total cholesterol and low-density lipoprotein levels and decreased high-density lipoprotein levels), alterations in metabolic enzyme activities (lipase, glycerol-3-phosphate dehydrogenase, and glucose-6-phosphate dehydrogenase), histological changes in the liver (micro- and macrovesicular steatosis) and the downregulation of peroxisome proliferator-activated receptor γ (PPARγ) in adipose tissue and the liver. Daily oral supplementation with Q, CA or BB for 6 weeks after NAFLD induction had a hypolipidemic action and modulated metabolic markers.ConclusionWe showed that an HFS diet is able to promote NAFLD, and our results suggest that CA and BB are promising complementary supplements that can ameliorate the metabolic disorders associated with an HFS diet; however, Q requires further investigation.

Highlights

  • Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease with a complex pathophysiology

  • Effect of an High fat high sucrose (HFS) diet and treatments on biochemical measurements By the end of 12 weeks of feeding with the HFS diet, our data demonstrated that the pair-fed groups in the laboratory model exhibited differences in their serum and hepatic tissue lipid profiles

  • Activity assays of the hepatic enzymes in the HFS-fed rats revealed a significant decrease (p < 0.001) in the glucose-6-phosphate dehydrogenase (G6PDH) activity (U/mg protein), a significant increase (p < 0.001) in the lipase activity and a non-significant difference in hepatic glycerol-3-phosphate dehydrogenase (G3PDH) activity compared with the standard diet (SD)-fed rats (Fig. 1c)

Read more

Summary

Introduction

Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease with a complex pathophysiology. The clinical features of NAFLD include obesity, insulin resistance (IR) and dyslipidemia. High level of caloric intake has been associated with many diet-induced complications, including metabolic syndrome, cardiovascular disease and non-alcoholic fatty liver disease (NAFLD) [1]. The clinical markers of NAFLD include obesity, insulin resistance (IR), and dyslipidemia [3]. The liver-specific deletion of PPARγ in mice established the role of this transcription factor as a prosteatotic factor in the development of NAFLD [12]. PPARγ inactivation promotes the efflux of free fatty acids (FFAs) from the liver and muscle while increasing fat mass, which increases insulin sensitivity [13]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call